Alexza
Alexza Pharmaceuticals focuses on the development of novel and proprietary products for the acute treatment of central nervous system disorders.
Business Model:
Revenue: $5M
Employees: 51-200
Rankings
Industries / Tags:
Detailed Alexza Information
Alexza was acquired by
Grupo Ferrer Internacional.
The acquisition happend on 2016-05-10.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 2091 Stierlin Court
City: Mountain View
State: CA
Zip: 94043
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$5M
Raised Total:$186M
Social
Metrics
1,178,074Website Global Rank
18,988Website Monthly Traffic
Twitter Followers
Description
Alexza Pharmaceuticals focuses on the development of novel and proprietary products for the acute treatment of central nervous system disorders.
Contact Phone:
+16509447000
Contact Email:
Alexza went public on 3/8/2006 on the NYSE
Listed Exchange:
NYSE
IPO Date:
3/8/2006
IPO Valuation:
$176M
Ticker Symbol:
ALXA
IPO Price:
$8/share
Amount Raised:
$44M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 6/2009 | Symphony Allegro |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
